In bone marrow samples from multiple myeloma patients, SFRP2 could be detected in 10/14 specimens, while only 1/5 bone marrow samples from patients without bone lesions scored positive for SFRP2 expression [70]. Here, SFRP2 is linked to AL amyloidosis.